Literature DB >> 2140804

Differential regulation of two glucose transporters in rat liver by fasting and refeeding and by diabetes and insulin treatment.

B Thorens1, J S Flier, H F Lodish, B B Kahn.   

Abstract

Two species of glucose transporter (GT) are present in the liver: the erythroid/brain GT and the newly characterized liver GT. No information is available regarding the functional role of these two species or whether their expression is regulated concordantly in states in which hepatic glucose uptake or output are markedly altered. In this study, we analyzed the effect of fasting and refeeding and streptozocin-induced diabetes and subsequent insulin treatment on the expression of the erythroid/brain and liver GT polypeptides and their mRNAs in rat liver. The erythroid/brain GT mRNA in livers of control rats corresponded to 1-3% of the amount of liver GT mRNA. After a 4-day fast, its level increased approximately 3-fold and represented 8-10% of the liver GT mRNA, whereas the corresponding protein increased 4-fold. In livers from diabetic rats, levels of the erythroid/brain GT mRNA increased up to 2.4-fold and gradually returned to normal with chronic insulin treatment. Levels of the corresponding protein were minimally altered. Levels of immunoreactive liver GTs were not significantly changed by 2 days of fasting, 7 or 14 days of diabetes, or subsequent insulin treatment for 3, 5, or 7 days but increased up to 75% with refeeding for 3-48 h. Liver GT mRNA levels minimally decreased in diabetic or insulin-treated rats, decreased 45% after a 2-day fast, and increased up to 5-fold on refeeding for 24 h.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2140804     DOI: 10.2337/diab.39.6.712

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  23 in total

Review 1.  Autonomic dysfunction of the beta-cell and the pathogenesis of obesity.

Authors:  Robert H Lustig
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Glycaemia regulates the glucose transporter number in the plasma membrane of rat skeletal muscle.

Authors:  D Dimitrakoudis; T Ramlal; S Rastogi; M Vranic; A Klip
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

3.  Restricted expression of the erythroid/brain glucose transporter isoform to perivenous hepatocytes in rats. Modulation by glucose.

Authors:  M Tal; D L Schneider; B Thorens; H F Lodish
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 4.  Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes.

Authors:  B B Kahn
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

5.  Anti-diabetic effects of mulberry (Morus alba L.) branches and oxyresveratrol in streptozotocin-induced diabetic mice.

Authors:  Eunyeong Ahn; Jimin Lee; Young-Hee Jeon; Sang-Won Choi; Eunjung Kim
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

6.  Overexpression of GLUT3 placental glucose transporter in diabetic rats.

Authors:  P Boileau; C Mrejen; J Girard; S Hauguel-de Mouzon
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Expression of glucose transporter 1 in adult and developing human peripheral nerve.

Authors:  P Muona; S Jaakkola; V Salonen; J Peltonen
Journal:  Diabetologia       Date:  1993-02       Impact factor: 10.122

8.  Insulin regulation of hepatic glucose transporter protein is impaired in chronic pancreatitis.

Authors:  D K Andersen; C L Ruiz; C F Burant
Journal:  Ann Surg       Date:  1994-06       Impact factor: 12.969

9.  Regulation of glucokinase and GLUT-2 glucose-transporter gene expression in pancreatic B-cells.

Authors:  M Tiedge; S Lenzen
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

10.  Differential expression of rat pancreatic islet beta-cell glucose transporter (GLUT 2), proinsulin and islet amyloid polypeptide genes after prolonged fasting, insulin-induced hypoglycaemia and dexamethasone treatment.

Authors:  L Koranyi; R Bourey; J Turk; M Mueckler; M A Permutt
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.